CCK1R2R^-/- ameliorates myocardial damage caused by unpredictable stress via altering fatty acid metabolism

References

• Aimo, A., Castiglione, V., Borrelli, C., Saccaro, L. F., Franzini, M., Masi, S., Emdin, M., & Giannoni, A. (2020). Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies. European Journal of Preventive Cardiology, 27(5), 1–14. https://doi.org/10.1177/2047487319870344
   Web of Science ®Google Scholar
• Buffolo, F., Tetti, M., Mulatero, P., & Monticone, S. (2022). Aldosterone as a mediator of cardiovascular damage. Hypertension, 79(9), 1899–1911. https://doi.org/10.1161/hypertensionaha.122.17964
   PubMed Web of Science ®Google Scholar
• Cevik-Aras, H., & Ekstrom, J. (2010). Anti-inflammatory action of cholecystokinin and melatonin in the rat parotid gland. Oral Diseases, 16(7), 661–667. https://doi.org/10.1111/j.1601-0825.2010.01672.x
   PubMed Web of Science ®Google Scholar
• Chen, X., Wan, W., Guo, Y., Ye, T., Fo, Y., Sun, Y., Qu, C., Yang, B., & Zhang, C. (2021). Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway. Molecular Medicine, 27(1), 100. https://doi.org/10.1186/s10020-021-00363-7
   PubMed Web of Science ®Google Scholar
• Creighton, J. V., de Souza Goncalves, L., Artioli, G. G., Tan, D., Elliott-Sale, K. J., Turner, M. D., Doig, C. L., & Sale, C. (2022). Physiological roles of carnosine in myocardial function and health. Advances in Nutrition, 13(5), 1914–1929. https://doi.org/10.1093/advances/nmac059
   PubMed Web of Science ®Google Scholar
• Das, S., Komnenov, D., Newhouse, L., Rishi, A. K., & Rossi, N. F. (2022). Paraventricular nucleus v(1a) receptor knockdown blunts neurocardiovascular responses to acute stress in male rats after chronic mild unpredictable stress. Physiology & Behavior, 253, 113867. https://doi.org/10.1016/j.physbeh.2022.113867
   PubMed Web of Science ®Google Scholar
• DiNicolantonio, J. J., Liu, J., & O’Keefe, J. H. (2018). Thiamine and cardiovascular disease: a literature review. Progress in Cardiovascular Diseases, 61(1), 27–32. https://doi.org/10.1016/j.pcad.2018.01.009
   PubMed Web of Science ®Google Scholar
• Djoussé, L., Weir, N. L., Hanson, N. Q., Tsai, M. Y., & Gaziano, J. M. (2012). Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure. Circulation Heart Failure, 5(6), 703–709. https://doi.org/10.1161/circheartfailure.112.967802
   PubMed Web of Science ®Google Scholar
• Durante, W. (2019). The emerging role of l-glutamine in cardiovascular health and disease. Nutrients, 11(9), 2092. https://doi.org/10.3390/nu11092092
   PubMed Web of Science ®Google Scholar
• Fang, M., Deng, J., Zhou, Q., Hu, Z., & Yang, L. (2022). Maslinic acid protects against pressure-overload-induced cardiac hypertrophy by blocking METTL3-mediated m(6)A methylation. Aging, 14(6), 2548–2557. https://doi.org/10.18632/aging.203860
   PubMedGoogle Scholar
• Han, Z. N., Lin, X. X., Wang, Y. Y., Ding, R., Hong, L., & Cui, X. (2022). Cholecystokinin octapeptide promotes ANP secretion through activation of NOX4-PGC-1alpha-PPARalpha/PPARgamma signaling in isolated beating rat atria. Oxidative Medicine and Cellular Longevity, 2022, 5905374–5905319. https://doi.org/10.1155/2022/5905374
   PubMed Web of Science ®Google Scholar
• Hasan, S., Bilal, N., Naqvi, S., Ashraf, G. M., Suhail, N., Sharma, S., & Banu, N. (2011). Multivitamin-mineral and vitamins (E + C) supplementation modulate chronic unpredictable stress-induced oxidative damage in brain and heart of mice. Biological Trace Element Research, 142(3), 589–597. https://doi.org/10.1007/s12011-010-8771-5
   PubMed Web of Science ®Google Scholar
• Hinterdobler, J., Schott, S., Jin, H., Meesmann, A., Steinsiek, A. L., Zimmermann, A. S., Wobst, J., Muller, P., Mauersberger, C., Vilne, B., Baecklund, A., Chen, C. S., Moggio, A., Braster, Q., Molitor, M., Krane, M., Kempf, W. E., Ladwig, K. H., Hristov, M., … Sager, H. B. (2021). Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis. European Heart Journal, 42(39), 4077–4088. https://doi.org/10.1093/eurheartj/ehab371
   PubMed Web of Science ®Google Scholar
• Hu, T., Wu, Q., Yao, Q., Jiang, K., Yu, J., & Tang, Q. (2022). Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Research Reviews, 81, 101706. https://doi.org/10.1016/j.arr.2022.101706
   PubMed Web of Science ®Google Scholar
• Jensen, M. D. (2006). Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors. Obesity, 14 Suppl 3, 143s–149s. https://doi.org/10.1038/oby.2006.294
   PubMed Web of Science ®Google Scholar
• Karwi, Q. G., Uddin, G. M., Ho, K. L., & Lopaschuk, G. D. (2018). Loss of metabolic flexibility in the failing heart. Frontiers in Cardiovascular Medicine, 5, 68. https://doi.org/10.3389/fcvm.2018.00068
   PubMed Web of Science ®Google Scholar
• Kuebler, U., Zuccarella-Hackl, C., Arpagaus, A., Wolf, J. M., Farahmand, F., von Känel, R., Ehlert, U., & Wirtz, P. H. (2015). Stress-induced modulation of NF-κB activation, inflammation-associated gene expression, and cytokine levels in blood of healthy men. Brain, Behavior, and Immunity, 46, 87–95. https://doi.org/10.1016/j.bbi.2014.12.024
   PubMed Web of Science ®Google Scholar
• Kurosawa, M., Iijima, S., Funakoshi, A., Kawanami, T., Miyasaka, K., Bucinskaite, V., & Lundeberg, T. (2001). Cholecystokinin-8 (CCK-8) has no effect on heart rate in rats lacking CCK-A receptors. Peptides, 22(8), 1279–1284. https://doi.org/10.1016/s0196-9781(01)00452-1
   PubMed Web of Science ®Google Scholar
• Lam, C. S., Lyass, A., Kraigher-Krainer, E., Massaro, J. M., Lee, D. S., Ho, J. E., Levy, D., Redfield, M. M., Pieske, B. M., Benjamin, E. J., & Vasan, R. S. (2011). Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation, 124(1), 24–30. https://doi.org/10.1161/CIRCULATIONAHA.110.979203
   PubMed Web of Science ®Google Scholar
• Lavine, J. A., Kibbe, C. R., Baan, M., Sirinvaravong, S., Umhoefer, H. M., Engler, K. A., Meske, L. M., Sacotte, K. A., Erhardt, D. P., & Davis, D. B. (2015). Cholecystokinin expression in the β-cell leads to increased β-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosis. American Journal of Physiology. Endocrinology and Metabolism, 309(10), E819–828. https://doi.org/10.1152/ajpendo.00159.2015
   PubMed Web of Science ®Google Scholar
• Lee, S. B., Lee, K. W., Wang, T., Lee, J. S., Jung, U. S., Nejad, J. G., Oh, Y. K., Baek, Y. C., Kim, K. H., & Lee, H. G. (2019). Intravenous administration of L-tryptophan stimulates gastrointestinal hormones and melatonin secretions: study on beef cattle. Journal of Animal Science and Technology, 61(4), 239–244. https://doi.org/10.5187/jast.2019.61.4.239
   PubMed Web of Science ®Google Scholar
• Liu, J., Hu, J., Tan, L., Zhou, Q., & Wu, X. (2021). Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats. BMC Cardiovascular Disorders, 21(1), 403. https://doi.org/10.1186/s12872-021-02209-w
   Web of Science ®Google Scholar
• Lund, A., Nordrehaug, J. E., Slettom, G., Solvang, S. H., Pedersen, E. K., Midttun, O., Ulvik, A., Ueland, P. M., Nygard, O., & Giil, L. M. (2020). Plasma kynurenines and prognosis in patients with heart failure. PLoS One, 15(1), e0227365. https://doi.org/10.1371/journal.pone.0227365
   PubMed Web of Science ®Google Scholar
• MacCarter, D., Vijay, N., Washam, M., Shecterle, L., Sierminski, H., & St Cyr, J. A. (2009). D-ribose aids advanced ischemic heart failure patients. International Journal of Cardiology, 137(1), 79–80. https://doi.org/10.1016/j.ijcard.2008.05.025
   PubMed Web of Science ®Google Scholar
• Mitręga, K., Zorniak, M., Varghese, B., Lange, D., Nożynski, J., Porc, M., Białka, S., & Krzemiński, T. F. (2011). Beneficial effects of l-leucine and l-valine on arrhythmias, hemodynamics and myocardial morphology in rats. Pharmacological Research, 64(3), 218–225. https://doi.org/10.1016/j.phrs.2011.04.011
   PubMed Web of Science ®Google Scholar
• Nadella, S., Ciofoaia, V., Cao, H., Kallakury, B., Tucker, R. D., & Smith, J. P. (2020). Cholecystokinin receptor antagonist therapy decreases inflammation and fibrosis in chronic pancreatitis. Digestive Diseases and Sciences, 65(5), 1376–1384. https://doi.org/10.1007/s10620-019-05863-5
   PubMed Web of Science ®Google Scholar
• Noreen, S., Rehman, H. U., Tufail, T., Badar Ul Ain, H., & Awuchi, C. G. (2023). Secoisolariciresinol diglucoside and anethole ameliorate lipid abnormalities, oxidative injury, hypercholesterolemia, heart, and liver conditions. Food Science & Nutrition, 11(6), 2620–2630. https://doi.org/10.1002/fsn3.3250
   PubMed Web of Science ®Google Scholar
• Oriyanhan, W., Yamazaki, K., Miwa, S., Takaba, K., Ikeda, T., & Komeda, M. (2005). Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart and Vessels, 20(6), 278–285. https://doi.org/10.1007/s00380-005-0841-9
   PubMed Web of Science ®Google Scholar
• Qipshidze-Kelm, N., Piell, K. M., Solinger, J. C., & Cole, M. P. (2013). Co-treatment with conjugated linoleic acid and nitrite protects against myocardial infarction. Redox Biology, 2, 1–7. https://doi.org/10.1016/j.redox.2013.10.009
   PubMed Web of Science ®Google Scholar
• Ritterhoff, J., Young, S., Villet, O., Shao, D., Neto, F. C., Bettcher, L. F., Hsu, Y. A., Kolwicz, S. C., Jr., Raftery, D., & Tian, R. (2020). Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis. Circulation Research, 126(2), 182–196. https://doi.org/10.1161/CIRCRESAHA.119.315483
   PubMed Web of Science ®Google Scholar
• Saia, R. S., Bertozi, G., Mestriner, F. L., Antunes-Rodrigues, J., Queiróz Cunha, F., & Cárnio, E. C. (2013). Cardiovascular and inflammatory response to cholecystokinin during endotoxemic shock. Shock, 39(1), 104–113. https://doi.org/10.1097/SHK.0b013e3182793e2e
   PubMed Web of Science ®Google Scholar
• Sara, J. D. S., Lerman, L. O., & Lerman, A. (2021). The endothelium is a key player in the vascular response to acute mental stress. European Heart Journal, 42(39), 4089–4091. https://doi.org/10.1093/eurheartj/ehab510
   PubMed Web of Science ®Google Scholar
• Sartor, D. M., & Verberne, A. J. (2002). Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 282(4), R1174–1184. https://doi.org/10.1152/ajpregu.00500.2001
   PubMed Web of Science ®Google Scholar
• Satoh, M., Matter, C. M., Ogita, H., Takeshita, K., Wang, C. Y., Dorn, G. W., 2nd., & Liao, J. K. (2007). Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation, 115(25), 3197–3204. https://doi.org/10.1161/CIRCULATIONAHA.106.657981
   PubMed Web of Science ®Google Scholar
• Starcke, K., & Brand, M. (2012). Decision making under stress: a selective review. Neuroscience and Biobehavioral Reviews, 36(4), 1228–1248. https://doi.org/10.1016/j.neubiorev.2012.02.003
   PubMed Web of Science ®Google Scholar
• Toko, H., Morita, H., Katakura, M., Hashimoto, M., Ko, T., Bujo, S., Adachi, Y., Ueda, K., Murakami, H., Ishizuka, M., Guo, J., Zhao, C., Fujiwara, T., Hara, H., Takeda, N., Takimoto, E., Shido, O., Harada, M., & Komuro, I. (2020). Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart. Scientific Reports, 10(1), 15553. https://doi.org/10.1038/s41598-020-72686-0
   PubMed Web of Science ®Google Scholar
• van der Pol, A., van Gilst, W. H., Voors, A. A., & van der Meer, P. (2019). Treating oxidative stress in heart failure: past, present and future. European Journal of Heart Failure, 21(4), 425–435. https://doi.org/10.1002/ejhf.1320
   PubMed Web of Science ®Google Scholar
• Velasco, C., Comesana, S., Conde-Sieira, M., Miguez, J. M., & Soengas, J. L. (2019). Effects of CCK-8 and GLP-1 on fatty acid sensing and food intake regulation in trout. Journal of Molecular Endocrinology, 62(3), 101–116. https://doi.org/10.1530/JME-18-0212
   PubMed Web of Science ®Google Scholar
• Wang, L., Hiller, H., Smith, J. A., de Kloet, A. D., & Krause, E. G. (2016). Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice. Physiological Genomics, 48(9), 667–676. https://doi.org/10.1152/physiolgenomics.00029.2016
   PubMed Web of Science ®Google Scholar
• Wei, Y., & Wang, B. (2021). The expression levels of plasma dimethylglycine (DMG), human maternally expressed gene 3 (MEG3), and Apelin-12 in patients with acute myocardial infarction and their clinical significance. Annals of Palliative Medicine, 10(2), 2175–2183. https://doi.org/10.21037/apm-21-122
   PubMed Web of Science ®Google Scholar
• Westfall, S., Caracci, F., Zhao, D., Wu, Q. L., Frolinger, T., Simon, J., & Pasinetti, G. M. (2021). Microbiota metabolites modulate the T helper 17 to regulatory T cell (Th17/Treg) imbalance promoting resilience to stress-induced anxiety- and depressive-like behaviors. Brain, Behavior, and Immunity, 91, 350–368. https://doi.org/10.1016/j.bbi.2020.10.013
   PubMed Web of Science ®Google Scholar
• Williamson, C., Gorelik, J., Eaton, B. M., Lab, M., de Swiet, M., & Korchev, Y. (2001). The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clinical Science, 100(4), 363–369. https://doi.org/10.1042/cs1000363
   PubMed Web of Science ®Google Scholar
• Wu, J., Cao, M., Hu, M., Gong, Y., Xue, J., Yang, Y., & Zhou, H. (2022). Intervention effects of okra extract on brain-gut peptides and intestinal microorganisms in sleep deprivation rats. Evidence-Based Complementary and Alternative Medicine, 2022, 9855411–9855413. https://doi.org/10.1155/2022/9855411
   PubMed Web of Science ®Google Scholar
• Wu, T., Yao, H., Zhang, B., Zhou, S., Hou, P., & Chen, K. (2021). 2021). Kappa opioid receptor agonist inhibits myocardial injury in heart failure rats through activating Nrf2/HO-1 pathway and regulating Ca(2+)-SERCA2a. Oxidative Medicine and Cellular Longevity, 2021, 7328437. https://doi.org/10.1155/2021/7328437
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., & Sano, M. (2022). Deranged myocardial fatty acid metabolism in heart failure. International Journal of Molecular Sciences, 23(2), 996. https://doi.org/10.3390/ijms23020996
   PubMed Web of Science ®Google Scholar
• Yu, B., Li, A. H., Metcalf, G. A., Muzny, D. M., Morrison, A. C., White, S., Mosley, T. H., Gibbs, R. A., & Boerwinkle, E. (2016). Loss-of-function variants influence the human serum metabolome. Science Advances, 2(8), e1600800. https://doi.org/10.1126/sciadv.1600800
   PubMed Web of Science ®Google Scholar
• Yue, Y., Guo, Y., & Yang, Y. (2017). Effects of dietary L-tryptophan supplementation on intestinal response to chronic unpredictable stress in broilers. Amino Acids, 49(7), 1227–1236. https://doi.org/10.1007/s00726-017-2424-3
   PubMed Web of Science ®Google Scholar
• Zeng, Q., Ou, L., Wang, W., & Guo, D. Y. (2020). Gastrin, cholecystokinin, signaling, and biological activities in cellular processes. Frontiers in Endocrinology, 11, 112. https://doi.org/10.3389/fendo.2020.00112
   PubMed Web of Science ®Google Scholar
• Zhao, X. Y., Ling, Y. L., Li, Y. G., Meng, A. H., & Xing, H. Y. (2005). Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats. World Journal of Gastroenterology, 11(22), 3405–3410. https://doi.org/10.3748/wjg.v11.i22.3405
   PubMed Web of Science ®Google Scholar